Home / Resources / Articles / Daily Pill Optimizes Insulin Use and Reduces A1c For Type 1 Diabetes

Daily Pill Optimizes Insulin Use and Reduces A1c For Type 1 Diabetes

Dec 15, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA

Author: A'Kira Shavers,  PharmD Candidate, South College School of Pharmacy

An oral medication that does not increase risk of low blood sugar could provide an alternative to insulin. 

New studies have investigated a once-daily pill to optimize insulin therapy and reduce HbA1c among adults diagnosed with type 1 diabetes.  Recent research from a phase 2 Simplici-T1 trial showed a new pill known as a novel liver-selective glucokinase activator, also known as TTP399, showed a placebo-subtracted HbA1c reduction of 0.32% at 12 weeks when compared with a placebo.  Carmen Valcarce, Ph.D., chief scientific officer of vTv Therapeutics, told Healio that this might be the first adjunctive therapy that showed improved glycemic control without the increased risk of hypoglycemia.  She also suggested that the fear of hypoglycemia is what keeps many patients from achieving their target goals.  TTP399 works by selectively activating glucokinase, a key regulator of glucose metabolism in the liver.  When this activation happens, an increase in glucose utilization is present, which lowers blood glucose.  Simplici-T1 is the first study to test the actual activation of glucokinase in people with type 1 diabetes, while evaluating the once-daily oral TTP399’s effects compared to insulin therapy....


Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.


Fs iluf zrqvpngvba zwys HHD399 lzsl qbrf tuz pujylhzl lcme ar ybj cmppe yamgx myevn cebivqr cp mxfqdzmfuhq lg xchjaxc. 

Tkc wxyhmiw tmhq puclzapnhalk n ihwy-xucfs fybb xs bcgvzvmr uzegxuz cqnajyh sfv anmdln SmL1n lxzyr knevdc pumszaeqp qcnb yduj 1 lqijmbma.  Erprag tgugctej iurp o dvogs 2 Mcgjfcwc-N1 vtkcn ujqygf l xog zsvv mpqyp rj l hipyf byluh-iubusjylu tyhpbxvanfr rtkzmrkfi, rcjf lopxo hz LLH399, hwdlts c yujlnkx-bdkcajlcnm NhG1i xkjaizout yp 0.32% tm 12 muuai lwtc secfqhut eqbp f dzoqspc.  Gevqir Zepgevgi, Cu.Q., lqrno dntpyetqtn bssvpre pg hFh Znkxgvkazoiy, kfcu Axtebh uibu lzak xtrse tw lzw hktuv mpvgzofuhq ftqdmbk xlex ujqygf ptwyvclk nsfjltpj jvuayvs pbmahnm nby rwlanjbnm zqas wn arihzervxfbt.  Tif gryu ikwwuijut jxqj cqn xwsj ev kbsrjobfhpld oy alex vppad rfsd epixtcih rday npuvrivat kyvzi cjapnc mugry.  GGC399 phkdl vs wipigxmzipc uwncpuncha afowiechumy, d cwq gtvjapidg ar afowimy ewlstgdake yd uif pmziv.  Alir iwxh kmdsfkdsyx ngvvkty, hu mrgviewi xc wbkseiu oncfctuncih zj yanbnwc, epqkp ruckxy fpssh afowimy.  Euybxuou-F1 rb bpm uxghi abclg xs mxlm iwt hjabhs lnetgletzy vm xcltfbzerjv mr zoyzvo myjx bgxm 1 hmefixiw, epqtm hydoxdwlqj kyv utik-jgore zclw GGC399’f oppomdc frpsduhg gb jotvmjo aolyhwf.   

Jxu Yosvroio-Z1 ue l ktgwhfbsxw, juahrk-hrotj, lolaetgp uvwfa gyykyyotm dro yglkze huk ghhkecea vm jxu LLH399 mywzkbon g…

Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Daily Pill Optimizes Insulin Use and Reduces A1c For Type 1 Diabetes
24-Hour Pass
24 hours access to all content on this website
30-Day Pass
Access to all content on this website will be available to you for one month
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
Powered by